According to the result of this meta-analysis, anti-U1 RNP antibody is a risk factor for PAH among CTD patients with a pooled OR of 5.30 (95%CI 2.96–9.48, p < 0.001). The gene discussed is U1; the disease is pulmonary arterial hypertension.